Pseudomonas and bronchial diseases;Pseudomonas et bronches

Medecine et Maladies Infectieuses

Volumn 37, Issue 6, 2007, Pages 300-304

  Mayaud, C ^a  

^a HÔPITAL TENON   (France)

Author keywords

Bronchial dilation; Cystic fibrosis; Obstructive bronchopneumonia; Pseudomonas aeruginosa

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CIPROFLOXACIN; NEOMYCIN; TOBRAMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BIOFILM; BRONCHUS DISEASE; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG CHOICE; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PSEUDOMONAS AERUGINOSA; REVIEW; TREATMENT PLANNING; FRANCE; INCIDENCE; MICROBIOLOGY; RISK ASSESSMENT;

BRONCHIAL DISEASES; FRANCE; HUMANS; INCIDENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK ASSESSMENT;

EID: 34250799235     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2007.02.008     Document Type: Review

References (31)

1. Balkanli K., Genc O., Dakak M., Gurko S., Gozubuyuk A., and Yucel O. Surgical management of bronchiectasis: analysis and short-term results in 238 patients. Eur. J. Cardiothorac. Surg. 24 (2003) 699-702
2. Benhamou D., Torabi H., Lecomte F., Cuvelier A., Hellot M.F., Pons J.L., and Muir J.F. Bronchectasies diffuses : étude bactériologique à partir d'une série de 127 infections avec prélèvements fiables chez 60 patients. Rev. Mal. Respir. 13 suppl (1996) R48
3. Monso E., Rosell A., Bonet G., Manterola J., Cardona P.J., Ruiz J., and Morera J. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur. Respir. J. 13 2 (1999) 338-342
4. Soler N., Torres A., Ewig S., Gonzalez J., Celis R., El-Ebiary M., et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (copd) requiring mechanical ventilation. Am. J. Respir. Crit. Care Med. 157 (1998) 1498-1505
5. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest 117 (2000) 380S-385S
6. Fagon J.Y., Chastre J., Trouillet J.L., Domart Y., Dombret M.C., Bornet M., Gibert C., et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am. Rev. Respir. Dis. 142 5 (1990) 1004-1008
7. Pela R., Marchesani F., Agostinelli C., Staccioli D., Cecarini L., Bassotti C., et al. Airways microbial flora in copd patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. Monaldi Arch. Chest Dis. 53 3 (1998) 262-267
8. Robinson P., Carzino R., Armstrong D., and Olinsky A. Pseudomonas cross-infection from cystic fibrosis patients to non-cystic fibrosis patients: implications for inpatient care of respiratory patients. J. Clin. Microbiol. 41 12 (2003) 741
9. Eller J., Ede A., Schaberg T., Niederman M.S., Mauch H., and Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 113 6 (1998) 1542-1548
10. Jaffré S., Benhamou D., Pons J.L., and Muir J.F. Acute exacerbation of copd: relationship between bacteriological data and lung function. Am. J. Respir. Crit. Care Med. 163 (2001) A770
11. Miravitlles M., Murio C., and Guerrero T. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. Eur. Respir. J. 17 (2001) 928-933
12. Wilson C.B., Jones P.W., O'Leary C.J., Hansell D.M., Cole P.J., and Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur. Respir. J. 10 8 (1997) 1754-1760
13. Ho P.L., Chan K.N., Ip M.S., Lam W.K., Ho C.S., Yuen K.Y., et al. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest 114 6 (1998) 1594-1598
14. Evans Sa T.S., Bosch B.J., Hardy C.C., and Woodhead M.A. Lung function in bronchiectasis: The influence of Pseudomonas aeruginosa. Eur. Respir. J. 9 8 (1996) 1601-1604
15. Miszkiel K.A., Wells A.U., Rubens M.B., Cole P.J., and Hansell D.M. Effects of airway infection by Pseudomonas aeruginosa: a computed tomographic study. Thorax 52 3 (1997) 260-264
16. Chakroun N., Benhamou D., Hellot M.F., Henry J., Janvresse A., Louvel J.P., et al. Longitudinal study of lung function and computed tomography in a cohort of 78 bronchiectasic patients. Am. J. Respir. Crit. Care Med. 163 (2001) A908
17. Gowan Jr. W., and Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60 (1996) 539-574
18. Wilson R. Bacteria, antibiotics and COPD. Eur. Respir. J. 17 (2001) 995-1007
19. Rosell A., Monso E., Soler N., Torres F., Angrill J., Riise G., et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch. Intern. Med. 165 (2005) 891-897
20. Lieberman D. Pseudomonal infections in patients with COPD: epidemiology and management. Am. J. Respir. Med. 2 (2003) 459-468
21. Lusardi M., Capelli A., Di Stephano A., Zaccaria S., Balbi B., and Donner C.F. Lower respiratory tract infections in chronic obstructive pulmonary disease outpatients with tracheostomy and persistent colonization by P. aeruginosa. Respir. Med. 97 (2003) 1205-1210
22. Patel I.S., Seemungal T.A.R., Wilks M., Lloyd-Owen S.J., Donaldson G.C., and Wedzicha J.A. Relationship between bacterial colonization and the frequency, character, and severity of COPD exacerbations. Thorax 57 (2002) 759-764
23. Foweraker J.E., Laughton C.R., Brown Jr. D.F., and Bilton D. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. J. Antimicrob. Chemother. 55 (2005) 921-927
24. Doring G., Conway S.P., Heigerman H.G., et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur. Respir. J. 16 (2000) 749-767 (Prise en charge du patient atteint de mucoviscidose. Conférence de consensus. Rev Mal Resp 2003 ; 20 : 3S7-3S27)
25. Smith A.L., Fiel S.B., Mayer-Hamblett N., et al. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotics administration: lack of an association in cystic fibrosis. Chest 123 (2003) 1495-1502
26. Frederiksen B., Koch C., and Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr. Pulmonol. 23 (1997) 330-335
27. Frederiksen B., Lamy S., Koch C., et al. Improved survival in the Danish center treated cystic fibrosis patients: results of aggressive treatment. Pediatr. Pulmonol. 21 (1996) 153-158
28. Ramsey B.W., Pepe M.S., Quan J.M., et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N. Engl. J. Med. 340 (1999) 23-30
29. SPLF. Recommandations pour la prise en charge de la BPCO. Exacerbations-Décompensations : antibiothérapie. Rev. Mal. Respir. 20 (2003) 4S65-4S68
30. Saiman L., Marshall B.C., Mayer-Hamblett N., et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomised controlled trial. Jama 290 (2003) 1749-1756
31. Mazières J., Murris M., Didier A., et al. Limited operation for severe multisegmental bilateral bronchiectasis. Ann. Thorac. Surg. 75 (2003) 382-387